Skip to main content
Premium Trial:

Request an Annual Quote

Euformatics Expands Latin American Presence With A&C Group Distribution Deal

NEW YORK – Euformatics said this week that it has entered into a distribution agreement with A&C Group to offer its Omnomics suite of interpretation and validation software for next-generation sequencing in Bolivia, Peru, and Paraguay.

The deal expands Espoo, Finland-based Euformatics' presence in Latin America, which already includes Brazil by virtue of a March distribution agreement with Síntese Biotecnologia.

"Starting this partnership with Euformatics puts us in a great position to help laboratories improve their operations with NGS," A&C Group President Enrique Aguinaga said in a statement. "The usability and flexibility of OmnomicsNGS means that even laboratories who are new to NGS and starting out small have easy and quick access to the information they need to make key analysis decisions and generate reports. In combination with OmnomicsQ, we can ensure that the quality of NGS data being generated is top-quality from the beginning."

Euformatics has been busy expanding through distribution partnerships. The firm moved into Central Asia, the Middle East, and Africa in late 2019 via an agreement with Dubai-based Alliance Global (AGBL Group).

The company has also expressed a desire to sell its products in Southeast Asia. CEO Tommi Kaasalainen specifically named Singapore, Thailand, and Malaysia as near-term targets, but did not rule out other countries.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more